The trinity of COVID-19: immunity, inflammation and intervention
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …
The epidemiology, diagnosis and treatment of COVID-19
P Zhai, Y Ding, X Wu, J Long, Y Zhong, Y Li - International journal of …, 2020 - Elsevier
In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 …
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from …
W Zhang, Y Zhao, F Zhang, Q Wang, T Li, Z Liu… - Clinical …, 2020 - Elsevier
The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all
over the world. Reports from China showed that about 20% of patients developed severe …
over the world. Reports from China showed that about 20% of patients developed severe …
Cytokine storm induced by SARS-CoV-2
P Song, W Li, J Xie, Y Hou, C You - Clinica chimica acta, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by the virus designated as severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely throughout the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread widely throughout the …
Candidate drugs against SARS-CoV-2 and COVID-19
DL McKee, A Sternberg, U Stange, S Laufer… - Pharmacological …, 2020 - Elsevier
Outbreak and pandemic of coronavirus SARS-CoV-2 in 2019/2020 will challenge global
health for the future. Because a vaccine against the virus will not be available in the near …
health for the future. Because a vaccine against the virus will not be available in the near …
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status
TM Abd El-Aziz, JD Stockand - Infection, Genetics and evolution, 2020 - Elsevier
Coronaviruses are a large group of viruses known to cause illnesses that vary between the
common cold and more severe diseases to include severe acute respiratory syndrome …
common cold and more severe diseases to include severe acute respiratory syndrome …
Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1
X Tang, RH Du, R Wang, TZ Cao, LL Guan, CQ Yang… - Chest, 2020 - Elsevier
Background Since the outbreak of coronavirus disease 2019 (COVID-19) in China in
December 2019, considerable attention has been focused on its elucidation. However, it is …
December 2019, considerable attention has been focused on its elucidation. However, it is …
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
H Liu, F Ye, Q Sun, H Liang, C Li, S Li… - Journal of enzyme …, 2021 - Taylor & Francis
COVID-19 has become a global pandemic and there is an urgent call for developing drugs
against the virus (SARS-CoV-2). The 3C-like protease (3CLpro) of SARS-CoV-2 is a …
against the virus (SARS-CoV-2). The 3C-like protease (3CLpro) of SARS-CoV-2 is a …
Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
Y Li, Z Xie, W Lin, W Cai, C Wen, Y Guan, X Mo… - Med, 2020 - cell.com
Background Antiviral therapies against the novel coronavirus SARS-CoV-2, which has
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
caused a global pandemic of respiratory illness called COVID-19, are still lacking. Methods …
[HTML][HTML] Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
ES Amirian, JK Levy - One health, 2020 - Elsevier
Recent international epidemics of coronavirus-associated illnesses underscore the urgent
medical and public health need for vaccine development and regulatory body approved …
medical and public health need for vaccine development and regulatory body approved …